Click the image to the left and log in to get your exclusive reader perks.
https://www.thedailytimes.com/business/tevogen-bio-announces-its-investigational-sars-cov-2-specific-t-cell-therapy-tvgn-489-is/article_3f50db92-2e9c-563a-951e-b1cbe1f6b291.html
Tevogen Bio Announces its Investigational SARS-CoV-2 Specific T cell Therapy, TVGN-489, Is Not Affected by Omicron Variant Following Research Team Review of all Reported Mutations
